Henrik Semb
Impact in
- Molecular Biology top 1%
- Pluripotent Stem Cells Research
- Wnt/β-catenin signaling in development and cancer
- Cancer-related gene regulation
- CRISPR and Genetic Engineering
- Surgery top 1%
- Pancreatic function and diabetes
Papers in
-
- Pluripotent Stem Cells Research 23
- Wnt/β-catenin signaling in development and cancer 12
- CRISPR and Genetic Engineering 9
- Metabolism, Diabetes, and Cancer 7
- Congenital heart defects research 5
- Surgery 40
- Pancreatic function and diabetes 36
- Co-authors
- Gerhard Christofori (6 shared papers)Ulf Dahl (6 shared papers)Anne‐Karina T. Perl (3 shared papers)Petra Wilgenbus (2 shared papers)Thomas Olivecrona (10 shared papers)Anders Ståhlberg (9 shared papers)Anders Sjödin (4 shared papers)Joakim Håkansson (4 shared papers)
In The Last Decade
Henrik Semb
74 papers receiving 6.8k citations
Henrik Semb's Hit Papers
Peers
Comparison fields: 5 of 129
- Molecular Biology 4.3k
- Surgery 2.0k
- Endocrinology, Diabetes and Metabolism 729
- Cell Biology 763
- Oncology 1.0k
Countries citing papers authored by Henrik Semb
This map shows the geographic impact of Henrik Semb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Semb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Semb more than expected).
Fields of papers citing papers by Henrik Semb
This network shows the impact of papers produced by Henrik Semb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Semb. The network helps show where Henrik Semb may publish in the future.
Co-authors
The 25 scholars most cited alongside Henrik Semb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A causal role for E-cadherin in the transition from adenoma to carcinoma Hit paper breakdown → | 1998 | 1169 |
| 2 | The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene Hit paper breakdown → | 1999 | 610 |
| 3 | 2004 | 308 | |
| 4 | 2008 | 272 | |
| 5 | 2013 | 227 | |
| 6 | 2004 | 220 | |
| 7 | 1987 | 205 | |
| 8 | 2009 | 198 | |
| 9 | Cadherins regulate aggregation of pancreatic β-cells in vivo Hit paper breakdown → | 1996 | 189 |
| 10 | 2004 | 180 | |
| 11 | 2018 | 177 | |
| 12 | 2006 | 158 | |
| 13 | 1999 | 138 | |
| 14 | 2007 | 116 | |
| 15 | 2006 | 115 | |
| 16 | 1998 | 114 | |
| 17 | 1999 | 109 | |
| 18 | 2009 | 108 | |
| 19 | 2010 | 105 | |
| 20 | 1987 | 105 |
About Henrik Semb
Henrik Semb is a scholar working on Molecular Biology, Surgery, Genetics, Endocrinology, Diabetes and Metabolism and Cell Biology, having authored 77 papers that have together received 7.0k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (36 papers), Pluripotent Stem Cells Research (23 papers), Wnt/β-catenin signaling in development and cancer (12 papers), Diabetes and associated disorders (10 papers), CRISPR and Genetic Engineering (9 papers), Metabolism, Diabetes, and Cancer (7 papers), Diabetes Management and Research (6 papers) and Congenital heart defects research (5 papers). The work is most often cited by research in Molecular Biology (4.3k citations), Surgery (2.0k citations), Endocrinology, Diabetes and Metabolism (729 citations), Cell Biology (763 citations) and Oncology (1.0k citations). Henrik Semb has collaborated with scholars based in Sweden, Denmark and Germany. Frequent co-authors include Gerhard Christofori, Ulf Dahl, Anne‐Karina T. Perl, Petra Wilgenbus, Thomas Olivecrona, Anders Ståhlberg, Anders Sjödin, Joakim Håkansson, Mikael Kubista and Xiaojie Xian. Their work appears in journals such as Stem Cells, PLoS ONE, Development, Developmental Biology and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.